These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 1253817

  • 1. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Jan; 35(1):161-8. PubMed ID: 1253817
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 3. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B, Naylor RJ.
    Psychopharmacologia; 1975 Jul 23; 43(1):69-74. PubMed ID: 1172258
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system.
    Bartholini G.
    J Pharm Pharmacol; 1976 May 23; 28(5):429-33. PubMed ID: 6752
    [Abstract] [Full Text] [Related]

  • 5. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A, MacDonald C.
    Pharmacol Biochem Behav; 1984 Jul 23; 21(1):97-101. PubMed ID: 6540455
    [Abstract] [Full Text] [Related]

  • 6. Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry.
    Maidment NT, Marsden CA.
    Neuropharmacology; 1987 Jul 23; 26(2-3):187-93. PubMed ID: 2438582
    [Abstract] [Full Text] [Related]

  • 7. Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry.
    Maidment NT, Marsden CA.
    Eur J Pharmacol; 1987 Apr 14; 136(2):141-9. PubMed ID: 3595718
    [Abstract] [Full Text] [Related]

  • 8. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
    Blackburn JR, Phillips AG.
    Psychopharmacology (Berl); 1989 Apr 14; 98(4):453-9. PubMed ID: 2570431
    [Abstract] [Full Text] [Related]

  • 9. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR, Budygin EA, Kovalev GI, Kudrin VS, Raevskiĭ KS.
    Biull Eksp Biol Med; 1992 Jul 14; 114(7):47-9. PubMed ID: 1358258
    [Abstract] [Full Text] [Related]

  • 10. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T, Fukushima H.
    Neuropharmacology; 1976 Oct 14; 15(10):601-7. PubMed ID: 1033478
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS, Hetey L, Morgenshtern R, Raevskiĭ KS, Olssner W.
    Farmakol Toksikol; 1987 Oct 14; 50(2):16-20. PubMed ID: 2884129
    [Abstract] [Full Text] [Related]

  • 12. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC, Davis JM.
    Life Sci; 1976 Sep 01; 19(5):725-31. PubMed ID: 986527
    [No Abstract] [Full Text] [Related]

  • 13. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C, Morgenstern R, Fink H, Ott T.
    Psychopharmacology (Berl); 1990 Sep 01; 100(3):399-403. PubMed ID: 1969173
    [Abstract] [Full Text] [Related]

  • 14. The production of asymmetry and circling behaviour following unilateral, intrastriatal administration of neuroleptic agents: a comparison of abilities to antagonise striatal function.
    Costall B, Kelly ME, Naylor RJ.
    Eur J Pharmacol; 1983 Dec 09; 96(1-2):79-86. PubMed ID: 6141060
    [Abstract] [Full Text] [Related]

  • 15. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B, Domeney AM, Naylor RJ, Tyers MB.
    Br J Pharmacol; 1987 Dec 09; 92(4):881-94. PubMed ID: 2962686
    [Abstract] [Full Text] [Related]

  • 16. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B, Naylor RJ.
    Br J Pharmacol; 1995 Dec 09; 116(7):2989-99. PubMed ID: 8680734
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens.
    Morgenstern R, Mende T, Gold R, Lemme P, Oelssner W.
    Pharmacol Biochem Behav; 1984 Oct 09; 21(4):501-6. PubMed ID: 6504948
    [Abstract] [Full Text] [Related]

  • 18. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R, Guerin JJ, Davis KL.
    Psychopharmacology (Berl); 1989 Oct 09; 98(3):386-91. PubMed ID: 2568659
    [Abstract] [Full Text] [Related]

  • 19. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.
    Zivkovic B, Guidotti A, Revuelta A, Costa E.
    J Pharmacol Exp Ther; 1975 Jul 09; 194(1):37-46. PubMed ID: 239221
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J.
    Eur J Pharmacol; 1983 May 20; 90(1):47-55. PubMed ID: 6135618
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.